This site is intended for healthcare professionals only
LoginRegister
Sun Pharma, Philogen complete patient enrollment in Phase III trial for Soft Tissue SarcomaSun Pharma concludes acquisition of Concert Pharma
Dr Bharati Pravin Pawar launches One Stop-Non-Stop digital job portal of Pharmacy Council of IndiaDr Bharati Pravin Pawar launches 'One Stop-Non-Stop' digital job portal of Pharmacy Council of India
Goa Govt to make Jan Aushadi counters mandatory at all pharmaciesGoa Govt to make Jan Aushadi counters mandatory at all pharmacies
USFDA approves intramuscular administration for Merck’s MMRV Family of Vaccines: M-M-RII, VARIVAX, ProQuadUSFDA approves intramuscular administration for Merck’s MMRV Family of Vaccines: M-M-RII, VARIVAX,...
Roche bags USFDA nod for companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for EnhertuRoche gets CDSCO Panel nod to import, market ophthalmic drug Faricimab solution
Present revised Phase III CT protocol : CDSCO Tells Hetero Lab on Antidiabetic FDC DrugPresent revised Phase III CT protocol : CDSCO Tells Hetero Lab on Antidiabetic FDC Drug
Way Indian pharma sector gained trust during COVID was unprecedented: PM Narendra ModiWay Indian pharma sector gained trust during COVID was unprecedented: PM Narendra Modi
Licences of 6 cough syrup manufacturers in Maha suspended for violation of rulesLicences of 6 cough syrup manufacturers in Maha suspended for violation of rules
Cancel manufacturing licence of Marion biotech: Centre recommends Uttar Pradesh Drug Controller AuthorityCancel manufacturing licence of Marion biotech: Centre recommends Uttar Pradesh Drug Controller...
Alembic Pharma secures USFDA approval for Travoprost Ophthalmic SolutionAlembic Pharma bags USFDA nod for Fluorouracil Injection
NPPA fixes retail price of FDC to treat Nutritional deficiencies marketed by AbbottNPPA fixes retail price of FDC to treat Nutritional deficiencies marketed by Abbott
USFDA broadens indication for Eli Lillys Verzenio in HR+, HER2-, Node-Positive, High Risk Early Breast CancerUSFDA broadens indication for Eli Lilly's Verzenio in HR+, HER2-, Node-Positive, High Risk Early...
X